European regulators OK Pfizer vaccine for children 12-15
The European Medicines Agency on Friday recommended that the use of the coronavirus vaccine made by Pfizer and BioNTech be expanded to children ages 12 to 15, a decision that…
The European Medicines Agency on Friday recommended that the use of the coronavirus vaccine made by Pfizer and BioNTech be expanded to children ages 12 to 15, a decision that…
The U.K.’s medicines regulator on Friday approved Janssen’s single-dose Covid-19 vaccine for use. Britain’s Medicines and Healthcare products Regulatory Agency said that doses were expected to be available in the…
Malaysia's prime minister announced Friday a near-total COVID 19 lockdown, limiting social and economic activities halted for two weeks to contain the growing number of cases. Prime Minister Muhyiddin Yassin…
India crossed another grim milestone Monday with over 300,000 people lost due to COVID 19, while the huge surge of infections seemed to be decreasing in big cities but increasing…
Moderna said Tuesday that its COVID-19 shot strongly protects kids as young as 12 years-old, potentially putting it on track to become the second vaccination option for kids against the…
A new study conducted by researchers in Spain has found that vaccinating people with both an Oxford-AstraZeneca COVID 19 vaccine and a Pfizer-BioNtech COVID 19 vaccine triggers a potent immune…
Following recent approvals extending Pfizer-BioNtech COVID 19 vaccine storage and administration, the FDA has approved a longer maximum storage time at common refrigerator temperatures. This development could solve many problems…
In a major move towards return to pre-pandemic life, The Centers for Disease Control and Prevention eased virus restrictions for vaccinated people on Thursday. The new guidelines allow them to…
The Food and Drug Administration said Monday that children 12 to 15 years old are now eligible to receive the Pfizer/BioNTech COVID-19 vaccine as it expanded its emergency use authorization.…
UN program signs Moderna deal for 500 million doses starting fourth quarter U.S. biotech company Moderna will provide up to 500 million doses for the U.N.-backed program to ship COVID-19…